Page 7 - Chief Technical Operations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Saniona AB: Saniona publishes its year-end report for 2020 Revenue was SEK 8.2 M (7.2 M) Operating loss was SEK -159.4 (-93.6 M) Net loss was SEK -73.4 M (-68.8 M) Earnings per share were SEK -1.79 (-2.67) Diluted earnings per share were SEK -1.75 (-2.67) Q4 2020 (Q4 2019 restated) Revenue was SEK 1.6 M (0.0 M) Operating loss was SEK -68.8 M (-28.2 M) Net loss was SEK -45.6 M (-6.8 M) Earnings per share were SEK -0.73 (-0.24) Diluted earnings per share were SEK -0.73 (-0.24) Business highlights in Q4 2020 Saniona achieved positive top-line Phase 2 results from the open-label extension study ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Saniona publishes its year-end report for 2020 Saniona ABMarch 17, 2021 GMT PRESS RELEASE Revenue was SEK 8.2 M (7.2 M) Operating loss was SEK -159.4 (-93.6 M) Net loss was SEK -73.4 M (-68.8 M) Earnings per share were SEK -1.79 (-2.67) Diluted earnings per share were SEK -1.75 (-2.67) Q4 2020 (Q4 2019 restated) Revenue was SEK 1.6 M (0.0 M) Operating loss was SEK -68.8 M (-28.2 M) Net loss was SEK -45.6 M (-6.8 M) Earnings per share were SEK -0.73 (-0.24) Diluted earnings per sha...

Baxter BioPharma Solutions And Moderna Announce Agreement For Fill/Finish Manufacturing Of Moderna COVID-19 Vaccine In USA Agreement to perform fill/finish services for approximately 60–90 million doses in the U.S. this year Manufacturing will take place at Baxter BioPharma Solutions’ Indiana facility Baxter International Inc. a global leader in sterile medication production and delivery, and Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that they have entered into an agreement for Baxter BioPharma Solutions to provide fil...

December 21, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the further expansion of its executive team with the appointments of Denelle Waynick as Chief Legal Officer and Kyle Haraldsen as Chief Technical Operations Officer. The positions will be based in the U.S. and will support Saniona’s advancement of clinical trials for Tesomet and SAN711 as well as the company’s growing U.S. presence.  “This has been a year of transformation for Saniona, evolving from a company focused on early-stage research to one capable of con...

Saniona AB: Saniona Appoints Chief Legal Officer and Chief Technical Operations Officer to Its Executive Team December 21, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the further expansion of its executive team with the appointments of Denelle Waynick as Chief Legal Officer and Kyle Haraldsen as Chief Technical Operations Officer. The positions will be based in the U.S. and will support Saniona's advancement of clinical trials for Tesomet and SAN711 as well as the company's growing U.S. presence. "This has been a year of tr...